Co-Authors
This is a "connection" page, showing publications co-authored by Jean-Yves Blay and Souad Assaad.
Connection Strength
3.098
-
Mortality of patients with solid and haematological cancers presenting with symptoms of COVID-19 with vs without detectable SARS-COV-2: a French nationwide prospective cohort study. Br J Cancer. 2021 08; 125(5):658-671.
Score: 0.951
-
Risk of death of patients with cancer presenting with severe symptoms of infection, with or without documented COVID-19: In reply to van Dam et al. Eur J Cancer. 2020 11; 139:68-69.
Score: 0.901
-
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR. Eur J Cancer. 2020 08; 135:251-259.
Score: 0.886
-
Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients. Ann Oncol. 2021 11; 32(11):1443-1444.
Score: 0.240
-
Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19. Lancet Microbe. 2021 Sep; 2(9):e424.
Score: 0.060
-
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis. Cell Death Differ. 2021 12; 28(12):3297-3315.
Score: 0.060